Engineered Materials for Cancer Immunotherapy.
Ontology highlight
ABSTRACT: Immunotherapy is a promising treatment modality for cancer as it can promote specific and durable anti-cancer responses. However, limitations to current approaches remain. Therapeutics administered as soluble injections often require high doses and frequent re-dosing, which can result in systemic toxicities. Soluble bolus-based vaccine formulations typically elicit weak cellular immune responses, limiting their use for cancer. Current methods for ex vivo T cell expansion for adoptive T cell therapies are suboptimal, and achieving high T cell persistence and sustained functionality with limited systemic toxicity following transfer remains challenging. Biomaterials can play important roles in addressing some of these limitations. For example, nanomaterials can be employed as vehicles
SUBMITTER: Cheung AS
PROVIDER: S-EPMC4665104 | biostudies-literature | 2015 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA